Erik Seitz
Researcher Prodigy
Despite being only nineteen Erik has already detected a potential drug-target for the prevention of cancer metastases and treatment of drug-resistance in prostate cancer. Talk about a wonderkid, right? Opinionated and bold, he is keen on understanding the human body as a whole system as he believes that the most efficient way to treat a disease is to find the correlations first, and through that journey, our search for the source of the problem becomes naturally more efficient.
